Norges Bank’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-34,752
| Closed | -$748K | – | 1350 |
|
|
2024
Q2 | $748K | Sell |
34,752
-26,099
| -43% | -$562K | ﹤0.01% | 1845 |
|
|
2024
Q1 | $1.64M | Sell |
60,851
-182,500
| -75% | -$4.92M | ﹤0.01% | 1755 |
|
|
2023
Q4 | $7.29M | Hold |
243,351
| – | – | ﹤0.01% | 1585 |
|
|
2023
Q3 | $4.99M | Hold |
243,351
| – | – | ﹤0.01% | 1674 |
|
|
2023
Q2 | $4.84M | Hold |
243,351
| – | – | ﹤0.01% | 1727 |
|
|
2023
Q1 | $4.17M | Sell |
243,351
-77,422
| -24% | -$1.33M | ﹤0.01% | 1807 |
|
|
2022
Q4 | $6.28M | Hold |
320,773
| – | – | ﹤0.01% | 1711 |
|
|
2022
Q3 | $5.12M | Hold |
320,773
| – | – | ﹤0.01% | 1757 |
|
|
2022
Q2 | $4.41M | Sell |
320,773
-7,800
| -2% | -$107K | ﹤0.01% | 1796 |
|
|
2022
Q1 | $5.21M | Sell |
328,573
-154,206
| -32% | -$2.45M | ﹤0.01% | 1859 |
|
|
2021
Q4 | $10.5M | Buy |
482,779
+151,100
| +46% | +$3.3M | ﹤0.01% | 1743 |
|
|
2021
Q3 | $9.91M | Sell |
331,679
-9,633
| -3% | -$288K | ﹤0.01% | 1771 |
|
|
2021
Q2 | $15.1M | Buy |
341,312
+13,302
| +4% | +$589K | ﹤0.01% | 1648 |
|
|
2021
Q1 | $14.6M | Buy |
328,010
+303,010
| +1,212% | +$13.4M | ﹤0.01% | 1664 |
|
|
2020
Q4 | $1.37M | Buy |
+25,000
| New | +$1.37M | ﹤0.01% | 1994 |
|